Search

Your search keyword '"Diseases -- Switzerland"' showing total 17 results
Start Over Descriptor "Diseases -- Switzerland"
17 results on '"Diseases -- Switzerland"'

1. New Gene Therapy Findings Has Been Reported by Investigators at World Health Organization (Disease Foci of Pharmaceutical Research and Development As Reflected In Applications for International Nonproprietary Names, 1953-2022)

Subjects
World Health Organization -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Diseases -- Switzerland, Gene therapy -- Reports
Abstract

2025 MAR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Biotechnology - Gene Therapy. According to news [...]

Published
2025

2. US lawmakers call on EPA to ban pesticide linked to Parkinson's disease; Politicians say use of common yet toxic paraquat can't be justified due to apparent health and environment risks

Subjects
Syngenta AG -- Political activity -- Environmental aspects, United States. Environmental Protection Agency -- Political activity -- Environmental aspects, Political activity, Political aspects, Environmental aspects, Health aspects, Environmental issue, Herbicides -- Political aspects -- Health aspects -- Environmental aspects, Diseases -- Switzerland, Pesticides regulation -- Political aspects -- Environmental aspects -- Health aspects, Agricultural chemicals industry -- Political activity -- Environmental aspects -- Political aspects -- Health aspects, Environmental protection -- Health aspects -- Political aspects -- Environmental aspects, Pesticides policy -- Political aspects -- Environmental aspects -- Health aspects
Published
2024

3. University of Zurich Details Findings in Influenza (Retrospective Modelling of the Disease and Mortality Burden of the 1918-1920 Influenza Pandemic In Zurich, Switzerland)

Subjects
Epidemics -- Switzerland, Mortality -- Switzerland, Diseases -- Switzerland, Influenza -- Health aspects -- Models -- Analysis, Health, University of Zurich
Abstract

2025 MAR 4 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Current study results on Influenza have been published. According to news reporting from [...]

Published
2025

6. World Health Organization Reports Findings in Ebola Virus (Guidance reconciliation and practice question prioritization for a World Health Organization's Ebola and Marburg Disease guideline)

Subjects
Elsevier Science Inc., World Health Organization, Diseases -- Switzerland, Marburg virus disease, Ebola virus, Public health
Abstract

2025 JAN 16 (VerticalNews) -- By a News Reporter-Staff News Editor at Politics & Government Week -- New research on RNA Viruses - Ebola Virus is the subject of a [...]

Published
2025

7. Reports Outline Parkinson's Disease Study Findings from University of Zurich (Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson's disease)

Subjects
University of Zurich -- Reports, Reports, Diseases -- Switzerland, Medical research -- Reports, Neurons -- Reports, Medicine, Experimental -- Reports
Abstract

2025 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Parkinson's disease. According to news reporting from Zurich, [...]

Published
2025

8. Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer's disease

Subjects
Roche Holding AG, Medical research, Medicine, Experimental, Diseases -- Switzerland, Biotechnology industry, Alzheimer's disease, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- - New data highlight the potential of the Roche Elecsys(R) Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer's disease related amyloid pathology with [...]

Published
2024

9. Data on Mental Health Diseases and Conditions Discussed by Researchers at Bern University of Applied Sciences (The ethical aspects of integrating sentiment and emotion analysis in chatbots for depression intervention)

Subjects
Analysis, Ethical aspects, Diseases -- Switzerland, Medical research -- Analysis, Mental health -- Analysis, Medicine, Experimental -- Analysis
Abstract

2024 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Fresh data on mental health diseases and conditions are presented in a new [...]

Published
2024

10. Novartis Pharmaceuticals AG Researchers Update Current Data on Life Sciences (Does the impact of medical publications vary by disease indication and publication type? An exploration using a novel, value-based, publication metric framework: the ...)

Subjects
Novartis Pharma AG, Diseases -- Switzerland, Medical research, Medical journals, Medicine, Experimental
Abstract

2024 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- New study results on life sciences have been published. According to news originating from [...]

Published
2024

11. New research on alpha-synuclein biomarker assays advance the field regarding quantification and disease differentiation

Subjects
Saia AG, Movement disorders, Diseases -- Switzerland, Electronic components industry, Business, News, opinion and commentary
Abstract

Four studies with important data regarding the biggest challenges of seed amplification assays (SAAs), a biomarker that could aid in early diagnosis and disease differentiation for Parkinson's disease, were released [...]

Published
2024

13. Rare Kidney Diseases Market Report 2024 to 2035, by Target Indications, Type of Molecule, Route of Administration and Key Geographies

Subjects
Novartis AG -- Forecasts and trends, Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Diseases -- Switzerland, Belimumab -- Forecasts and trends, Kidney diseases -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, [...]

Published
2024

14. Inherited Retinal Disease Market Size and Share to Grow by 2034, Assesses DelveInsight | Key Companies - Spark Therapeutics, Alkeus Pharmaceuticals, Novartis Pharmaceuticals, Beacon Therapeutics, GenSight Biologics, Ocugen, AbbVie

Subjects
Novartis Pharma AG -- Forecasts and trends, Business -- Research, Diseases -- Switzerland, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Inherited Retinal Disease Market Insights report includes a comprehensive understanding of current treatment practices, inherited retinal disease [...]

Published
2024

15. Inherited Retinal Disease Market Size and Share to Grow by 2034, Assesses DelveInsight | Key Companies - Spark Therapeutics, Alkeus Pharmaceuticals, Novartis Pharmaceuticals, Beacon Therapeutics, GenSight Biologics, Ocugen, AbbVie

Subjects
Novartis Pharma AG -- Forecasts and trends, Reports, Forecasts and trends, Market trend/market analysis, Business research -- Forecasts and trends -- Reports, Voretigene neparvovec -- Reports -- Forecasts and trends, Aflibercept -- Forecasts and trends -- Reports, Diseases -- Switzerland, Pharmaceutical industry -- Forecasts and trends, Business -- Research
Abstract

2024 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- DelveInsight's Inherited Retinal Disease Market Insights report includes a comprehensive understanding of current treatment [...]

Published
2024

16. 2023 Report on Novartis AG's Technology Activities with Details of Estimated ICT Budgets and Major ICT Contracts

Subjects
Novartis AG -- Contracts, Diseases -- Switzerland, Pharmaceutical industry -- Contracts, Contract agreement, Telecommunications industry
Abstract

(GlobeNewswire) - The 'Novartis AG - Digital Transformation Strategies' report has been added to ResearchAndMarkets.com's offering. Novartis AG (Novartis) is a pharmaceutical company engaged in discovery, development, manufacturing, and marketing [...]

Published
2023

17. FDA approves a novel Novartis drug

Author

Whalen, Jeanne

Subjects
United States. Food and Drug Administration -- Powers and duties, Novartis AG -- Product introduction, Diseases -- Switzerland, Diseases -- Causes of, Diseases -- Genetic aspects, Diseases -- Drug therapy, Drug approval -- Reports, Genetic disorders -- Drug therapy, Administrative agencies -- Powers and duties, Pharmaceutical industry -- Product introduction, Company marketing practices, News, opinion and commentary, Ilaris (Medication) -- Licensing, certification and accreditation, Ilaris (Medication) -- Marketing, Ilaris (Medication) -- Product introduction
Abstract

Ilaris, a drug from Novartis AG used to treat cryopyrin-associated periodic syndrome, or CAPS, has been given approval by the United States Food and Drug Administration, The disease is extremely rare, an inherited disorder which is caused by the mutation in a single gene. Consequently, the drug Ilaris is likely to be one of the most expensive drugs in the world.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results